These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 18160389

  • 1. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L, Thornton L, O'Flanagan D, Johnson H, Barry M.
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [Abstract] [Full Text] [Related]

  • 2. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF, Chen TH.
    Vaccine; 2009 Nov 12; 27(48):6770-6. PubMed ID: 19735755
    [Abstract] [Full Text] [Related]

  • 3. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
    Vimolket T, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 2005 May 12; 36(3):693-9. PubMed ID: 16124440
    [Abstract] [Full Text] [Related]

  • 4. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK, Hutton G, Das Dores Pascoal E.
    Health Policy Plan; 2005 Jan 12; 20(1):50-9. PubMed ID: 15689430
    [Abstract] [Full Text] [Related]

  • 5. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
    Oddone EZ, Cowper PA, Hamilton JD, Feussner JR.
    Health Serv Res; 1993 Apr 12; 28(1):97-121. PubMed ID: 8463111
    [Abstract] [Full Text] [Related]

  • 6. Cost-utility of universal hepatitis A vaccination in Canada.
    Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.
    Vaccine; 2007 Dec 12; 25(51):8536-48. PubMed ID: 17996339
    [Abstract] [Full Text] [Related]

  • 7. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A.
    Hepatology; 1999 Feb 12; 29(2):548-52. PubMed ID: 9918934
    [Abstract] [Full Text] [Related]

  • 8. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.
    Pediatr Infect Dis J; 2003 Oct 12; 22(10):904-14. PubMed ID: 14551492
    [Abstract] [Full Text] [Related]

  • 9. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX, Dang RB, Zhang WD, Liang XF, Cui FQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct 12; 29(10):1003-8. PubMed ID: 19173882
    [Abstract] [Full Text] [Related]

  • 10. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY, Billah K, Lieu TA, Weinstein MC.
    Am J Prev Med; 2006 Jun 12; 30(6):498-506. PubMed ID: 16704944
    [Abstract] [Full Text] [Related]

  • 11. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E, Spada E, National Surveillance System for Acute Viral Hepatitis (SEIEVA) Collaborating Group.
    Clin Infect Dis; 2008 Mar 15; 46(6):868-75. PubMed ID: 18269332
    [Abstract] [Full Text] [Related]

  • 12. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
    Rein DB, Weinbaum CM.
    Vaccine; 2008 Oct 03; 26(42):5331-3. PubMed ID: 18706957
    [Abstract] [Full Text] [Related]

  • 13. [Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai].
    Wu GY, Gong YL, Yu SL, Shao RT, Qin HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun 03; 25(6):474-8. PubMed ID: 15231120
    [Abstract] [Full Text] [Related]

  • 14. [Cost-effectiveness analysis of different alternatives of universal vaccination against hepatitis B in the region of Murcia].
    Guillén Grima F, Espín Ríos MI.
    Med Clin (Barc); 1995 Feb 04; 104(4):130-6. PubMed ID: 7898156
    [Abstract] [Full Text] [Related]

  • 15. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E, Shattock AG, Fielding JF.
    Am J Gastroenterol; 2000 Jan 04; 95(1):223-6. PubMed ID: 10638588
    [Abstract] [Full Text] [Related]

  • 16. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M, Mangen MJ, van de Laar M, de Wit A.
    Vaccine; 2009 Feb 18; 27(8):1254-60. PubMed ID: 19118594
    [Abstract] [Full Text] [Related]

  • 17. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J, Li RC, Yang JY, Li YP, Chen XR, Xu ZY, Liu CB, Cao HL, Zhao K, Ni DM.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 18; 11(4):203-5. PubMed ID: 12716514
    [Abstract] [Full Text] [Related]

  • 18. [The use of decision making analysis for evaluating hepatitis B inoculation strategy].
    Zhuang GH, Xu HW.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar 18; 27(2):69-73. PubMed ID: 8354107
    [Abstract] [Full Text] [Related]

  • 19. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
    Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA.
    Am J Gastroenterol; 2002 Mar 18; 97(3):721-8. PubMed ID: 11922569
    [Abstract] [Full Text] [Related]

  • 20. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
    Kerleau M, Flori YA, Nalpas B, Lanoé JL, Berthelot P, Fardeau-Gautier M.
    Rev Epidemiol Sante Publique; 1995 Mar 18; 43(1):48-60. PubMed ID: 7892516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.